Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07597239 · ClinicalTrials.gov registry record · NA
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
A NA study, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT07597239: Active NA study, sponsored by Massachusetts General Hospital.
NCT07597239 is a NA study that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07597239, a NA study, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a blood clotting test called thromboelastography with platelet mapping (TEG-PM) can guide blood-thinning medication decisions in adults 18 years and older with peripheral artery disease (PAD) who have undergone leg artery open or endovascular surgery. The main questions it aims to answer are: * Can TEG-PM results improve blood-thinning medication levels in participants at high risk for blood clots after surgery? * Can adjusting blood-thinning medications based on TEG-PM results lower the rate of blood clots forming in their revascularized leg after surgery? Participants will: * Have blood samples taken before surgery and at 1 week, 1 month, 2 months, 3 months, 6 months, and up to 9 months after surgery * Have blood-thinning medications (aspirin, clopidogrel, and/or ticagrelor) adjusted based on TEG-PM results during the first 3 months after surgery * Have one additional blood test to check if clopidogrel is working properly * Have their medical records reviewed for 6 months after their last visit to check on their health outcomes
Interventions
- DRUG Aspirin
- DRUG Clopidogrel
- DRUG Ticagrelor
- DIAGNOSTIC_TEST Platelet Reactivity Testing
- DIAGNOSTIC_TEST Thromboelastography with Platelet Mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-12-14 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07597239
The ClinicalTrials.gov registry entry for NCT07597239 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Aspirin is the first listed.
NCT07597239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07597239 about?
NCT07597239 is a clinical study titled "Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization". The goal of this clinical trial is to learn if a blood clotting test called thromboelastography with platelet mapping (TEG-PM) can guide blood-thinning medication decisions in adults 18 years and older with peripheral artery disease (PAD) who have undergone leg artery open or endovascular surgery. T...
What is the current status of trial NCT07597239?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2022-12-14. Estimated completion is 2026-06.
What interventions are being tested in trial NCT07597239?
The interventions under investigation include: Aspirin (DRUG), Clopidogrel (DRUG), Ticagrelor (DRUG), Platelet Reactivity Testing (DIAGNOSTIC_TEST), Thromboelastography with Platelet Mapping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07597239?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.